Save Lives Through Organ Donation
Did you know that February 14 is National Donor Day? There are more than 100,000 people on the U.S. national waiting list for kidney donations. Wait time is affected by multiple factors, including blood type
January Is Glaucoma Awareness Month!
The COVID-19 pandemic and its ongoing aftermath has served to highlight the critical importance of clinical trials, as well as the challenges of conducting them.
How to Recruit Patients for Clinical Trials
The COVID-19 pandemic and its ongoing aftermath has served to highlight the critical importance of clinical trials, as well as the challenges of conducting them.
Helping Patients Become Better Health Partners: Responsum Stays True to Its Roots Despite Explosive Growth
When Responsum Health founder Andy Rosenberg appeared on the Health Literacy Out Loud podcast with host Helen Osborne, Responsum’s first app—for idiopathic pulmonary fibrosis—was still months away from its official launch. Andy’s impetus for creating
Women’s Access to Essential Healthcare is a Fundamental Human Right
Since its inception, Responsum Health’s mission has been to improve patients’ knowledge and confidence, support their needs and concerns, and empower them to advocate for themselves and live their best lives. We have striven to
Responsum Health Joins Other Healthcare Leaders and Innovators at the ViVE 2022 Health Conference
To my amazing team of colleagues at Responsum and all of you who have supported us along the way, thank you! We are really doing it!
Catch Responsum Health at the 2022 ViVE Conference
Our Responsum Health is heading to Miami! Our Founder and CEO Andrew Rosenberg will be on hand as both an attendee and presenter at this year’s ViVE 2022 Conference for Health Information Technology, joining over
Transcript: Andy Rosenberg discusses Long COVID on StartUp Health Now
Logan Plaster: Welcome to StartUp Health Now, the podcast about entrepreneurs and innovators re-imagining the future of health. I’m Logan Plaster. Today’s show is pulled from a recent interview. I had with Andrew Rosenberg, CEO